GKOS vs SYF · rev $336.2M vs rev $11.19B
Glaukos Corp (GKOS) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
SYF (SYF) common stock.
Latest reported GKOS revenue for 2026-06-30 was $336.2M. Net income was -$38.2M. GKOS currently screens at market cap $7.63B.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
GKOS currently screens at market cap $7.63B. SYF currently screens at market cap $0.
Not investment advice. Open the GKOS and SYF stock pages for the full models.
Not investment advice.